Related Experiment Video
Updated: Dec 24, 2025

A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit
Published on: July 13, 2019
Taurolidine lock solution for catheter-related bloodstream infections in pediatric patients: A meta-analysis
Yan Sun1, Guanghui Wan1, Liping Liang1
1Zaozhuang Traditional Chinese Medicine Hospital, Zaozhuang, Shandong, P.R. China.
Insights
Taurolidine lock solutions significantly reduce catheter-related bloodstream infections (CRBSIs) in pediatric patients. Further high-quality trials are needed to confirm these findings for central venous catheter (CVC) use.
Area of Science:
- Pediatric Infectious Diseases
- Medical Device Infections
- Pharmacological Interventions
Background:
- Catheter-related bloodstream infections (CRBSIs) are a significant cause of morbidity and mortality in pediatric patients with central venous catheters (CVCs).
- Taurolidine lock solutions are utilized to mitigate CRBSIs in both adult and pediatric populations.
Purpose of the Study:
- To systematically evaluate the efficacy of taurolidine lock solutions in preventing CRBSIs in pediatric patients through a meta-analysis.
- To determine the impact of taurolidine on CRBSI incidence and catheter removal rates in children.
Main Methods:
- A comprehensive literature search was conducted across multiple databases (PubMed, EMBASE, Cochrane Library, etc.) up to November 1, 2019.
- Included studies were randomized controlled trials (RCTs) comparing taurolidine lock solutions with control for CRBSI prevention in pediatric patients.
- Meta-analysis was performed on data from four eligible RCTs.
Main Results:
- Taurolidine significantly reduced the total number of CRBSIs compared to control (RR: 0.23; 95% CI: 0.13, 0.40).
- A statistically significant reduction in CRBSI incidence (events per 1000 catheter days) was observed with taurolidine (MD: -1.12; 95% CI: -1.54, -0.71).
- No significant difference was found in the number of catheters removed due to infection between taurolidine and control groups (RR: 0.68; 95% CI: 0.22, 2.10).
Conclusions:
- Taurolidine lock solutions show potential in significantly reducing CRBSIs in pediatric patients using central venous catheters.
- The current evidence base is limited by the quality of the included studies.
- Further large-scale, high-quality randomized controlled trials are necessary to validate these findings.
Abstract:
Infection is one of the most commonly described complications, and a major cause of morbidity and mortality in pediatric patients treated using central venous catheters (CVCs). Taurolidine lock solutions have been used to decrease catheter-related bloodstream infections (CRBSIs) in both adult and pediatric patients. The purpose of this study was to systematically search the literature and conduct a meta-analysis to determine the efficacy of taurolidine in reducing CRBSI in children. We conducted an electronic search of the PubMed, EMBASE, Cochrane Library, TRIP Database, CINAHL, and Google Scholar databases for articles published up to 1st November 2019. Eligible studies included randomized controlled trials (RCTs) comparing the effects of taurolidine with control for preventing CRBSI in pediatric patients. Four studies were included. Our results indicated a statistical significant reduction in the total number of CRBSI with taurolidine as compared to control (RR: 0.23; 95% CI:0.13, 0.40; I2 = 0%; P<0.00001). The pooled analysis also indicated a statistical significant reduction in the incidence of CRBSI (defined as the number of CRBSI events/1000 catheter days) in the taurolidine group (MD: -1.12; 95% CI:-1.54, -0.71; I2 = 1%; P<0.00001). The number of catheters removed due to infection or suspected infection was not significantly different between the two groups (RR: 0.68; 95% CI:0.22, 2.10; I2 = 56%; P = 0.50) (Fig 5). The quality of the included studies was not high. The use of taurolidine as a catheter locking solution may significantly reduce CRBSI in pediatric patients. However, the quality of current evidence is not high and further high-quality large scale RCTs are needed to corroborate our results.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care

